<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03084978</url>
  </required_header>
  <id_info>
    <org_study_id>2016-7021</org_study_id>
    <nct_id>NCT03084978</nct_id>
  </id_info>
  <brief_title>Conscious Sedation vs General Anesthesia in TAVR Patients</brief_title>
  <official_title>Randomized Prospective Study in Transcatheter Aortic Valve Replacement Patients- Conscious Sedation VS. General Anesthesia Examining the Effect on Operative Time</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial investigating the effect of general anesthesia versus&#xD;
      conscious sedation on operative times in patients undergoing transcatheter aortic valve&#xD;
      replacement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study was never approved by the IRB&#xD;
  </why_stopped>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time-on-table</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>time to patient on table to surgical drapes down&#xD;
time to patient on table to when deemed safe for transport by anesthesiologist and surgeon</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with serious adverse events</measure>
    <time_frame>within 30 days</time_frame>
    <description>deaths&#xD;
conversion from sedation to intubation&#xD;
hypersensitivity reactions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>within 30 days</time_frame>
    <description>ICU length of stay (days)&#xD;
Hospital length of stay (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmissions</measure>
    <time_frame>within 30 days</time_frame>
    <description>Number of patients readmitted within 30 days of initial procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with Valve Complications</measure>
    <time_frame>within 30 days</time_frame>
    <description>paravalvular leak on echocardiogram&#xD;
pacemaker requirement&#xD;
vascular complications requiring reintervention&#xD;
post-procedure requiring valve dilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast usage</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>Amount of contrast used in mL for procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>Amount of time fluoroscopy used</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Post-procedure Complications</measure>
    <time_frame>within 30 days</time_frame>
    <description>TIA or Stroke&#xD;
Myocardial Infarction&#xD;
Bleeding&#xD;
Infection</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Procedure start to 30 days</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire at 30 days</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>General Anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will undergo general anesthesia with endotracheal intubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conscious Sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo conscious sedation anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General Anesthesia</intervention_name>
    <description>General anesthesia by standard endotracheal intubation.</description>
    <arm_group_label>General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conscious Sedation</intervention_name>
    <description>Conscious sedation</description>
    <arm_group_label>Conscious Sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signed informed consent, signed Health Insurance Portability and Accountability Act&#xD;
             (HIPAA) documentation)&#xD;
&#xD;
          2. Age over 18 years of age.&#xD;
&#xD;
          3. Women of child bearing age must have a negative urine or serum pregnancy test.&#xD;
&#xD;
          4. Clinical indication for a transfemoral aortic valve replacement.&#xD;
&#xD;
          5. English or Spanish speaking&#xD;
&#xD;
          6. No evidence of neurological impairment as defined by a NIHSS ≤ 1 and modified Rankin&#xD;
             scale (mRS) ≤ 2 within 7 days prior to randomization.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. BMI &gt; 40&#xD;
&#xD;
          2. Diagnosis of severe obstructive sleep apnea based on previous polysomnography, with&#xD;
             severe defined as an apnea-hypopnea index (AHI) &gt;30 episodes/hr.&#xD;
&#xD;
          3. High risk for aspiration such as severe esophageal disease (e.g. achalasia,&#xD;
             gastroparesis, etc).&#xD;
&#xD;
          4. Inability to lie supine for more than 30 minutes.&#xD;
&#xD;
          5. Marginal femoral vessels with concern for possible conversion to transapical or&#xD;
             transaortic access.&#xD;
&#xD;
          6. Patient refusal&#xD;
&#xD;
          7. Patient involved in another research study&#xD;
&#xD;
          8. Psychiatric condition precluding ability to provide informed consent&#xD;
&#xD;
          9. History of clinical stroke within 3 months prior to randomization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph DeRose, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <reference>
    <citation>Brecker SJ, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, Linke A; ADVANCE Study Investigators. Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study). Am J Cardiol. 2016 Apr 15;117(8):1332-8. doi: 10.1016/j.amjcard.2016.01.027. Epub 2016 Jan 28.</citation>
    <PMID>26892451</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>March 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2017</study_first_posted>
  <last_update_submitted>June 12, 2019</last_update_submitted>
  <last_update_submitted_qc>June 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

